Page 3 - Ipca Labs

Nifty view and stock call by HDFC Securities: Buy Ipca Labs, Bharti Airtel

Bharti Airtel's move remained resilient during the downtrend which the market witnessed in the current calendar year

Ipca Lab, Pidilite Industries: Two stocks HDFC Securities is bullish on

The primary trend of Ipca Lab's stock has been bullish with higher tops and higher bottoms on the weekly and monthly charts

Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply

The medicine is considered one of the possible treatments for the Covid-19

Strong domestic and export growth to drive Ipca Laboratories' earnings

Ipca's first half performance holds testimony to its robust growth with India business growing in mid-teens

US FDA pulls up Ipca Labs for manufacturing violations at Gujarat plant

The United States Food and Drug Administration (USFDA) inspection of its Piparia (Silvassa) formulations manufacturing unit in August resulted in three observations, it added.

IPCA Labs: Strong prospects, attractively valued

Resolution of FDA issues a key positive for the stock and should be sorted in FY16, so investors should be patient

Ipca Labs arm acquires 80% stake in US-based Bayshore Pharma for $10.286 mn

The acquisition of a majority stake in Bayshore will allow Ipca to commercialise its registered generic drug products in the US market

Ipca Labs dips as order for ACTs unlikely from Global Fund

Global Fund will not source ACTs because of warning letter issued by USFDA